PRARAM 9 HOSPITAL Plc. (PR9): 3Q25 Earnings In Line; 4Q25E Muted By Higher Tax
We upgrade our rating to Buy (from Outperform) with 19% upside to 2026E fair value of Bt25.50, based on a 4.5% required return, and very limited...
100 Views
PRARAM 9 HOSPITAL Plc. (PR9): 3Q25E Profit To Outperform Peers In The Healthcare Sector
3Q25E core profit is expected to show the strongest YoY and QoQ growth in the sector, supported by continued improvement in international patient...
195 Views
PRARAM 9 HOSPITAL Plc.: International Patients To Remain Key Growth Driver In The Next Few Years
We initiate coverage on PR9 with a “Buy” rating. KTX Valuation Metrics is positive on fundamentals, with the stock price implying 12% upside to the...
258 Views
Krungthai XSpring Technical Eng. November 11, 2025
Asian bourses surged as optimism grew that the US government shutdown might soon end, while investors shifted their focus to 3Q25 earnings results...
133 Views
Krungthai XSpring Technical Eng. November 10, 2025
Concerns that the AI sector may be entering a bubble phase, triggering selling pressure on the SET. The index has yet to establish a clear pattern...
114 Views